1. Home
  2. REVB vs HYFM Comparison

REVB vs HYFM Comparison

Compare REVB & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.00

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$1.11

Market Cap

4.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REVB
HYFM
Founded
2020
1977
Country
United States
United States
Employees
9
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
REVB
HYFM
Price
$1.00
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
69.5K
30.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$134,252,000.00
Revenue This Year
N/A
$57.44
Revenue Next Year
N/A
$5.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.79
52 Week High
$3.34
$4.78

Technical Indicators

Market Signals
Indicator
REVB
HYFM
Relative Strength Index (RSI) 28.61 48.38
Support Level $0.83 $0.82
Resistance Level $1.40 $1.09
Average True Range (ATR) 0.06 0.10
MACD -0.02 0.01
Stochastic Oscillator 0.00 30.11

Price Performance

Historical Comparison
REVB
HYFM

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

Share on Social Networks: